JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor Patients

JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing... Pathology & Oncology Research https://doi.org/10.1007/s12253-018-0443-3 LETTER TO THE EDITOR JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor Patients 1,2 3 1 Matthew K. Stein & Lindsay K. Morris & Mike G. Martin Received: 21 November 2017 /Accepted: 30 May 2018 Arányi Lajos Foundation 2018 Main Text undetermined significance (VUS) were included. All variants had >99% detection confidence based upon allele frequency Non-receptor tyrosine kinase (nRTK) pathways are aberrantly and amplicon coverage. In order to classify VUS, in silico activated in cancer, and mutations in nRTKs have potential analysis with PolyPhen-2 was utilized to predict pathogenicity therapeutic and prognostic importance. Consisting of 10 fam- [2]. Any VUS predicted-damaging with in silico analysis we ilies, the 32 known human nRTKs each include a TKD made denote VUSp. VUSs were then classified as occurring within of N and C-terminal lobes necessary for catalytic activity, as or outside of the TKD; PSKD lesions were also detailed for well as varying regulatory regions including Src homology 2 JAK1–3. (SH2) and 3 (SH3), and in the case of the Janus kinases a 346 patients (79 breast, 110 colon and 157 non-small cell PSKD which is also bi-lobed [1]. Tumor http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pathology & Oncology Research Springer Journals

JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor Patients

Loading next page...
 
/lp/springer_journal/jak-pseudokinase-domain-variants-highlight-nrtk-vuss-identified-with-PaXDxn6a84
Publisher
Springer Netherlands
Copyright
Copyright © 2018 by Arányi Lajos Foundation
Subject
Biomedicine; Cancer Research; Oncology; Pathology; Immunology; Biomedicine, general
ISSN
1219-4956
eISSN
1532-2807
D.O.I.
10.1007/s12253-018-0443-3
Publisher site
See Article on Publisher Site

Abstract

Pathology & Oncology Research https://doi.org/10.1007/s12253-018-0443-3 LETTER TO THE EDITOR JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor Patients 1,2 3 1 Matthew K. Stein & Lindsay K. Morris & Mike G. Martin Received: 21 November 2017 /Accepted: 30 May 2018 Arányi Lajos Foundation 2018 Main Text undetermined significance (VUS) were included. All variants had >99% detection confidence based upon allele frequency Non-receptor tyrosine kinase (nRTK) pathways are aberrantly and amplicon coverage. In order to classify VUS, in silico activated in cancer, and mutations in nRTKs have potential analysis with PolyPhen-2 was utilized to predict pathogenicity therapeutic and prognostic importance. Consisting of 10 fam- [2]. Any VUS predicted-damaging with in silico analysis we ilies, the 32 known human nRTKs each include a TKD made denote VUSp. VUSs were then classified as occurring within of N and C-terminal lobes necessary for catalytic activity, as or outside of the TKD; PSKD lesions were also detailed for well as varying regulatory regions including Src homology 2 JAK1–3. (SH2) and 3 (SH3), and in the case of the Janus kinases a 346 patients (79 breast, 110 colon and 157 non-small cell PSKD which is also bi-lobed [1]. Tumor

Journal

Pathology & Oncology ResearchSpringer Journals

Published: Jun 3, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off